Literature DB >> 20940395

Alternative cyclin D1 splice forms differentially regulate the DNA damage response.

Zhiping Li1, Xuanmao Jiao, Chenguang Wang, L Andrew Shirley, Hany Elsaleh, Olav Dahl, Min Wang, Evi Soutoglou, Erik S Knudsen, Richard G Pestell.   

Abstract

The DNA damage response (DDR) activates downstream pathways including cell cycle checkpoints. The cyclin D1 gene is overexpressed or amplified in many human cancers and is required for gastrointestinal, breast, and skin tumors in murine models. A common polymorphism in the human cyclin D1 gene is alternatively spliced, resulting in cyclin D1a and D1b proteins that differ in their carboxyl terminus. Cyclin D1 overexpression enhances DNA damage-induced apoptosis. The role of cyclin D1 and the alternative splice form in regulating the DDR is not well understood. Herein cyclin D1a overexpression enhanced the DDR as characterized by induction of γH2AX phosphorylation, the assembly of DNA repair foci, specific recruitment of DNA repair factors to chromatin, and G(2)-M arrest. Cyclin D1 deletion in fibroblasts or small interfering RNA-mediated reduction of endogenous cyclin D1 in colon cancer cells reduced the 5-fluorouracil-mediated DDR. Mechanistic studies showed that cyclin D1a, like DNA repair factors, elicited the DDR when stably associated with chromatin. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940395      PMCID: PMC2970762          DOI: 10.1158/0008-5472.CAN-10-0312

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  D1 in G2.

Authors:  Charles J Sherr
Journal:  Cell Cycle       Date:  2002-01       Impact factor: 4.534

2.  DNA replication arrest in XP variant cells after UV exposure is diverted into an Mre11-dependent recombination pathway by the kinase inhibitor wortmannin.

Authors:  C L Limoli; R Laposa; J E Cleaver
Journal:  Mutat Res       Date:  2002-12-29       Impact factor: 2.433

3.  Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line.

Authors:  J M Coco Martin; A Balkenende; T Verschoor; F Lallemand; R Michalides
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

Review 4.  Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance.

Authors:  Wilhelm Henning; Horst Werner Stürzbecher
Journal:  Toxicology       Date:  2003-11-15       Impact factor: 4.221

5.  The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle.

Authors:  N C Denko; A J Giaccia; J R Stringer; P J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.

Authors:  Chenguang Wang; Nagarajan Pattabiraman; Jian Nian Zhou; Maofu Fu; Toshiyuki Sakamaki; Chris Albanese; Zhiping Li; Kongming Wu; James Hulit; Peter Neumeister; Phyllis M Novikoff; Michael Brownlee; Philipp E Scherer; Joan G Jones; Kathleen D Whitney; Lawrence A Donehower; Emily L Harris; Thomas Rohan; David C Johns; Richard G Pestell
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 7.  Chk1 and Chk2 kinases in checkpoint control and cancer.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Cancer Cell       Date:  2003-05       Impact factor: 31.743

8.  Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.

Authors:  David A Solomon; Ying Wang; Sejal R Fox; Tah C Lambeck; Sarah Giesting; Zhengdao Lan; Adrian M Senderowicz; Claudio J Conti; Erik S Knudsen
Journal:  J Biol Chem       Date:  2003-05-12       Impact factor: 5.157

9.  Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.

Authors:  M Pagano; A M Theodoras; S W Tam; G F Draetta
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

10.  Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.

Authors:  J Y Kato; M Matsuoka; D K Strom; C J Sherr
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

View more
  59 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

2.  ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.

Authors:  Mathew C Casimiro; Marco Crosariol; Emanuele Loro; Adam Ertel; Zuoren Yu; William Dampier; Elizabeth A Saria; Alex Papanikolaou; Timothy J Stanek; Zhiping Li; Chenguang Wang; Paolo Fortina; Sankar Addya; Aydin Tozeren; Erik S Knudsen; Andrew Arnold; Richard G Pestell
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

Review 3.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

Review 4.  DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.

Authors:  Claire Gourzones-Dmitriev; Alboukadel Kassambara; Surinder Sahota; Thierry Rème; Jérôme Moreaux; Pascal Bourquard; Dirk Hose; Philippe Pasero; Angelos Constantinou; Bernard Klein
Journal:  Cell Cycle       Date:  2013-08-09       Impact factor: 4.534

5.  Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans.

Authors:  K Hemminki; L Musak; V Vymetalkova; Z Smerhovsky; E Halasova; O Osina; L Letkova; A Försti; L Vodickova; J Buchancova; P Vodicka
Journal:  Leukemia       Date:  2013-11-25       Impact factor: 11.528

Review 6.  Inherited genetic susceptibility to multiple myeloma.

Authors:  G J Morgan; D C Johnson; N Weinhold; H Goldschmidt; O Landgren; H T Lynch; K Hemminki; R S Houlston
Journal:  Leukemia       Date:  2013-11-19       Impact factor: 11.528

7.  Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation.

Authors:  C Chalermrujinanant; W Michowski; G Sittithumcharee; F Esashi; S Jirawatnotai
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

8.  Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells.

Authors:  Tsutomu Shimura; Yasushi Ochiai; Naoto Noma; Toshiyuki Oikawa; Yui Sano; Manabu Fukumoto
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

9.  The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module.

Authors:  Ke Chen; Kongming Wu; Xuanmao Jiao; Liping Wang; Xiaoming Ju; Min Wang; Gabriele Di Sante; Shaohua Xu; Qiong Wang; Kevin Li; Xin Sun; Congwen Xu; Zhiping Li; Mathew C Casimiro; Adam Ertel; Sankar Addya; Peter A McCue; Michael P Lisanti; Chenguang Wang; Richard J Davis; Graeme Mardon; Richard G Pestell
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

10.  Dachshund binds p53 to block the growth of lung adenocarcinoma cells.

Authors:  Ke Chen; Kongming Wu; Shaoxin Cai; Wei Zhang; Jie Zhou; Jing Wang; Adam Ertel; Zhiping Li; Hallgeir Rui; Andrew Quong; Michael P Lisanti; Aydin Tozeren; Ceylan Tanes; Sankar Addya; Michael Gormley; Chenguang Wang; Steven B McMahon; Richard G Pestell
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.